Eastman Chemical
EMN
63.25
-0.86
-1.34%
Eastman Chemical
US · EMN
#1730 by market cap
Listed 1970
63.25
-0.86
-1.34%
Live - 5344 symbols - heartbeat 487s ago
· 2026-10-07 19:54
After-hours
63.25
0.00%
- Market cap
- 7.23B
- P/E (TTM)i
- 16.47
- P/Bi
- 1.19
- EPSi
- 4.10
- Div yieldi
- 5.30%
- 52W posi
- 36%
Reader sentiment
Are you bullish or bearish on EMN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Mixed / stable
- The number of reporting institutions increased by 1 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 95.11% +0.01pp
- Institutions
- 750 +1
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund78.40%
Hedge Fund5.71%
Public Company4.22%
Private Company2.51%
Government Pension Fund2.38%
Sovereign Wealth Fund1.17%
Individual/Insider0.80%
Family Office/Trust0.34%
Insurance Company0.24%
Other4.23%
Top holders as of 2026-06-30
BlackRock
14.81% · 16.94M sh
Vanguard Portfolio Management, LLC
6.61% · 7.55M sh
Vanguard Capital Management, LLC
5.15% · 5.88M sh
Dimensional Fund Advisors
4.52% · 5.16M sh
State Street Global Advisors
3.65% · 4.17M sh
Putnam LLC
2.49% · 2.85M sh
MFS Investment Management
2.33% · 2.66M sh
EARNEST Partners, LLC
2.10% · 2.40M sh
Capital Research
1.92% · 2.19M sh
Allspring Global Investments, LLC
1.91% · 2.18M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 39 buys · 11 sells
| Name | Role | Stake |
|---|---|---|
| Mark Costa | Chairperson & CEO | 0.44% |
| Brad Lich | Executive Vice President | 0.09% |
| Stephen Crawford | Executive VP of Manufacturing & Chief Sustainability Officer | 0.06% |
| William McLain | Chief Financial Officer | 0.06% |
| Renee Hornbaker | Independent Director | 0.02% |
| B. Smith | Senior Vice President of Additives & Functional Products | 0.02% |
| Christopher Killian | Chief Technology Officer | 0.02% |
| Julie Holder | Independent Director | 0.02% |
| Julie McAlindon | Senior VP of Regions & Chief Supply Chain Officer | 0.02% |
| Eric Butler | Independent Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-03 | Adrian Holt | Chief Human Resources Officer | Open Market Disposition | -3,283 | $71.31 |
| 2026-05-31 | Adrian Holt | Chief Human Resources Officer | Derivative Exercise and Sale | -1,058 | $75.49 |
| 2026-05-31 | Adrian Holt | Chief Human Resources Officer | Derivative Exercise and Retained | +3,283 | -- |
| 2026-05-06 | Donald Slager | Director | Other Acquisition | +1,628 | -- |
| 2026-05-06 | James O’Brien | Independent Director | Other Acquisition | +1,628 | -- |
| 2026-05-06 | Renee Hornbaker | Independent Director | Other Acquisition | +1,628 | -- |
| 2026-05-06 | Brett Begemann | Independent Director | Other Derivative Acquisition | +1,628 | -- |
| 2026-05-06 | Damon Audia | Director | Other Derivative Acquisition | +1,628 | -- |
| 2026-05-06 | Julie Holder | Independent Director | Other Acquisition | +1,628 | -- |
| 2026-05-06 | Humberto Alfonso | Independent Director | Other Derivative Acquisition | +1,628 | -- |
| 2026-05-06 | Eric Butler | Independent Director | Other Acquisition | +1,628 | -- |
| 2026-05-06 | Kim Mink | Independent Director | Other Derivative Acquisition | +1,628 | -- |
| 2026-05-06 | Linnie Haynesworth | Independent Director | Other Acquisition | +1,628 | -- |
| 2026-05-04 | Adrian Holt | Chief Human Resources Officer | Open Market Disposition | -1,709 | $77.05 |
| 2026-05-04 | Adrian Holt | Chief Human Resources Officer | Derivative Sale to Issuer | -2,271 | $77.29 |
| 2026-04-07 | Donald Slager | Director | Other Derivative Acquisition | +408 | -- |
| 2026-04-07 | James O’Brien | Independent Director | Other Derivative Acquisition | +408 | -- |
| 2026-04-07 | Renee Hornbaker | Independent Director | Other Derivative Acquisition | +408 | -- |
| 2026-04-07 | Brett Begemann | Independent Director | Other Derivative Acquisition | +1,567 | -- |
| 2026-04-07 | Damon Audia | Director | Other Derivative Acquisition | +1,260 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.